• Cereno Scientific will hold an extraordinary general meeting on December 15, 2026, at MAQS Advokatbyrå's premises in Gothenburg, Sweden.
• Shareholders will vote on amendments enabling a rights issue of units comprising series B shares and series TO6 and TO7 warrants.
• Proposed amendments would raise maximum share capital to SEK 1.73 billion and the maximum number of shares to 17,295,408,116.
• The board seeks authorization until the next annual general meeting to issue series B shares and warrants, with or without preferential rights.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cereno Scientific AB published the original content used to generate this news brief on November 13, 2026, and is solely responsible for the information contained therein.